ANTIBIOTIC SUSCEPTIBILITY AND BETA-LACTAMASE PRODUCTION IN CLINICAL ISOLATES OF ENTEROBACTER SPP

被引:14
作者
LINDH, E [1 ]
DORNBUSCH, K [1 ]
JALAKAS, K [1 ]
FORSGREN, A [1 ]
机构
[1] KAROLINSKA INST,DEPT CLIN MICROBIOL,S-10401 STOCKHOLM 60,SWEDEN
关键词
Antibiotic susceptibility; Enterobacter spp; β-lactamase production;
D O I
10.1111/j.1699-0463.1990.tb01058.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The in vitro susceptibility of 237 clinical isolates of Enterobacter spp. (E. aerogenes, E. agglomerans and E. cloacae; 41, 64 and 132 respectively) to 16 different antibiotics is described. Four quinolones (ciprofloxacin, lomefloxacin, norfloxacin and ofloxacin), two new cephalosporins (cefpirome and cefepime) and imipenem, all showed high activity against the three Enterobacter species tested (MIC50 ≤ 0.125 mg/l, MIC90 ≤ 0.5 mg/l). Also the aminoglycosides gentamicin and tobramycin were highly active antibiotics (MIC50 ≤ 0.5 mg/l, MIC90 ≤ 1.0 mg/l). The susceptibility of β-lactam-antibiotics to β-lactamase produced by Enterobacter spp. was evaluated, and imipenem and cefepime were found to be most stable. Different methods for detection of inducible β-lactamases were used, the agar dilution method being more sensitive than the double-disc diffusion test. Elevated β-lactamase production was detected, via induction, in 83% of E. aerogenes strains and 70% of E. cloacae strains, with cefamandole used as the substrate and cefoxitin as the inducer. Constitutive, high level enzyme production was detected in 7 and 13% respectively of the E. aerogenes and the E. cloacae strains. In all the strains of E. agglomerans, 10% of E. aerogenes and 13% of E. cloacae, no β-lactamases could be detected with the methods studied.
引用
收藏
页码:462 / 470
页数:9
相关论文
共 42 条
[1]   INFLUENCE OF BACTERIAL BETA-LACTAMASE PRODUCTION ON SUSCEPTIBILITY IN AGAR OR BROTH TO NEW CEPHALOSPORINS [J].
ADAMSSON, L ;
DORNBUSCH, K ;
HALLANDER, HO .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 :153-162
[3]   INVITRO AMINOGLYCOSIDE RESISTANCE OF GRAM-NEGATIVE BACILLI AND STAPHYLOCOCCI ISOLATED FROM BLOOD IN SWEDEN 1980-1984 [J].
BENGTSSON, S ;
BERNANDER, S ;
BRORSON, JE ;
DORNBUSCH, K ;
FORSGREN, A ;
HALLANDER, H ;
HENNING, C ;
HOLM, S ;
MALMBORG, AS ;
NILSSON, L .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1986, 18 (03) :257-263
[4]   INVITRO STUDIES OF BMY-28142, A NEW BROAD-SPECTRUM CEPHALOSPORIN [J].
BODEY, GP ;
HO, DH ;
LEBLANC, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (02) :265-269
[5]   ENTEROBACTER-ASBURIAE SP-NOV, A NEW SPECIES FOUND IN CLINICAL SPECIMENS, AND REASSIGNMENT OF ERWINIA-DISSOLVENS AND ERWINIA-NIMIPRESSURALIS TO THE GENUS ENTEROBACTER AS ENTEROBACTER-DISSOLVENS COMB-NOV AND ENTEROBACTER-NIMIPRESSURALIS COMB-NOV [J].
BRENNER, DJ ;
MCWHORTER, AC ;
KAI, A ;
STEIGERWALT, AG ;
FARMER, JJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1986, 23 (06) :1114-1120
[6]  
BUSCH K, 1989, ANTIMICROB AGENTS CH, V33, P264
[7]   EVALUATION OF DISK APPROXIMATION AND AGAR DILUTION INDUCTION TESTS FOR DEMONSTRATION OF INVITRO ANTAGONISM OF CEFOTAXIME BY CEFOXITIN IN ENTEROBACTER SPECIES [J].
CHANDLER, SW ;
NOLTE, FS .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1987, 6 (04) :476-478
[8]   CIPROFLOXACIN, A QUINOLONE CARBOXYLIC-ACID COMPOUND ACTIVE AGAINST AEROBIC AND ANAEROBIC-BACTERIA [J].
CHIN, NX ;
NEU, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (03) :319-326
[9]  
Cowan ST., 1974, BACTERIAL CHARACTERS, V2
[10]   INDUCIBLE TYPE-I BETA-LACTAMASES OF GRAM-NEGATIVE BACTERIA AND RESISTANCE TO BETA-LACTAM ANTIBIOTICS [J].
CURTIS, NAC ;
EISENSTADT, RL ;
RUDD, C ;
WHITE, AJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 17 (01) :51-61